Abstract
Background: Headache in migraine patients plays an important role in their quality of life. Objectives: This study aimed to compare the effectiveness of transdiagnostic treatment and schema therapy in sleep quality and clinical symptoms of migraine in women with migraines in 2022. Methods: This semi-experimental study was conducted with a pre-test, mid-test, post-test, and follow-up with a control group. The statistical population included all women aged 20 to 40 years diagnosed with migraine in Shahrekord, Iran, in 2022. A total of 45 individuals were selected as the sample from the women referring to specialized clinics in Shahrekord using the available sampling method and taking into account the inclusion criteria of the subjects. Moreover, the subjects were randomly assigned into two experimental groups and one control group (each group with 15 subjects). The research tools included the Ahvaz Migraine Questionnaire (Najarian, 1997), the Sleep Quality Scale (Buysse et al., 1989), the transdiagnostic treatment protocol (Barlow et al., 2017), and the schema therapy protocol (Young et al., 2003). To analyze the data, multivariate and univariate analysis of covariance was used using SPSS software (version 27). Results: The results showed that there was a significant difference in the overall mean scores of migraine clinical symptoms and sleep quality between the two groups of transdiagnostic treatment and schema therapy (P = 0.001). In general, it can be concluded that the transdiagnostic treatment method had a greater effect on the clinical syndrome scores of migraine and sleep quality than the schema therapy method (P = 0.001). Conclusions: The results supported the effect of transdiagnostic treatment and schema therapy, and paying attention to these two treatment methods is of particular importance for women with migraines. Therefore, the results of this study can become the basis for interventions to help migraine patients.